vs
agilon health, inc.（AGL）与艾诺斯（ENS）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是艾诺斯的1.7倍（$1.6B vs $919.1M），艾诺斯净利率更高（9.8% vs -12.0%，领先21.9%），agilon health, inc.同比增速更快（3.1% vs 1.4%），艾诺斯自由现金流更多（$171.3M vs $-23.5M），过去两年艾诺斯的营收复合增速更高（0.5% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
艾诺斯是全球领先的工业储能系统及技术供应商，主营备用电源、动力电源类电池的生产，同时还提供电池充电器、电力设备、电池配件及户外设备防护机箱等相关产品，可充分满足各类工业场景的储能需求。
AGL vs ENS — 直观对比
营收规模更大
AGL
是对方的1.7倍
$919.1M
营收增速更快
AGL
高出1.7%
1.4%
净利率更高
ENS
高出21.9%
-12.0%
自由现金流更多
ENS
多$194.8M
$-23.5M
两年增速更快
ENS
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $919.1M |
| 净利润 | $-188.9M | $90.4M |
| 毛利率 | — | 30.1% |
| 营业利润率 | -12.3% | 13.5% |
| 净利率 | -12.0% | 9.8% |
| 营收同比 | 3.1% | 1.4% |
| 净利润同比 | -78.5% | -21.3% |
| 每股收益（稀释后） | — | $2.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLENS
| Q4 25 | $1.6B | $919.1M | ||
| Q3 25 | $1.4B | $951.3M | ||
| Q2 25 | $1.4B | $893.0M | ||
| Q1 25 | $1.5B | $974.8M | ||
| Q4 24 | $1.5B | $906.2M | ||
| Q3 24 | $1.5B | $883.7M | ||
| Q2 24 | $1.5B | $852.9M | ||
| Q1 24 | $1.6B | $910.7M |
净利润AGLENS
| Q4 25 | $-188.9M | $90.4M | ||
| Q3 25 | $-110.2M | $68.4M | ||
| Q2 25 | $-104.4M | $57.5M | ||
| Q1 25 | $12.1M | $96.5M | ||
| Q4 24 | $-105.8M | $114.8M | ||
| Q3 24 | $-117.6M | $82.3M | ||
| Q2 24 | $-30.7M | $70.1M | ||
| Q1 24 | $-6.1M | $60.9M |
毛利率AGLENS
| Q4 25 | — | 30.1% | ||
| Q3 25 | — | 29.1% | ||
| Q2 25 | — | 28.4% | ||
| Q1 25 | — | 31.2% | ||
| Q4 24 | — | 32.9% | ||
| Q3 24 | — | 28.5% | ||
| Q2 24 | — | 27.9% | ||
| Q1 24 | — | 27.9% |
营业利润率AGLENS
| Q4 25 | -12.3% | 13.5% | ||
| Q3 25 | -9.1% | 9.7% | ||
| Q2 25 | -8.3% | 9.7% | ||
| Q1 25 | -1.4% | 13.5% | ||
| Q4 24 | -7.1% | 15.7% | ||
| Q3 24 | -9.2% | 11.2% | ||
| Q2 24 | -2.9% | 10.7% | ||
| Q1 24 | -0.4% | 8.9% |
净利率AGLENS
| Q4 25 | -12.0% | 9.8% | ||
| Q3 25 | -7.7% | 7.2% | ||
| Q2 25 | -7.5% | 6.4% | ||
| Q1 25 | 0.8% | 9.9% | ||
| Q4 24 | -6.9% | 12.7% | ||
| Q3 24 | -8.1% | 9.3% | ||
| Q2 24 | -2.1% | 8.2% | ||
| Q1 24 | -0.4% | 6.7% |
每股收益（稀释后）AGLENS
| Q4 25 | — | $2.40 | ||
| Q3 25 | — | $1.80 | ||
| Q2 25 | — | $1.46 | ||
| Q1 25 | — | $2.39 | ||
| Q4 24 | — | $2.88 | ||
| Q3 24 | — | $2.01 | ||
| Q2 24 | — | $1.71 | ||
| Q1 24 | — | $1.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $450.1M |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $1.9B |
| 总资产 | $1.3B | $4.0B |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资AGLENS
| Q4 25 | $173.7M | $450.1M | ||
| Q3 25 | $171.7M | $388.6M | ||
| Q2 25 | $171.4M | $346.7M | ||
| Q1 25 | $136.9M | $343.1M | ||
| Q4 24 | $188.2M | $463.2M | ||
| Q3 24 | $148.2M | $407.9M | ||
| Q2 24 | $109.5M | $344.1M | ||
| Q1 24 | $111.7M | $333.3M |
总债务AGLENS
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $802.0M |
股东权益AGLENS
| Q4 25 | $126.7M | $1.9B | ||
| Q3 25 | $306.1M | $1.9B | ||
| Q2 25 | $408.9M | $1.9B | ||
| Q1 25 | $500.3M | $1.9B | ||
| Q4 24 | $471.0M | $1.8B | ||
| Q3 24 | $574.9M | $1.8B | ||
| Q2 24 | $676.6M | $1.8B | ||
| Q1 24 | $689.3M | $1.8B |
总资产AGLENS
| Q4 25 | $1.3B | $4.0B | ||
| Q3 25 | $1.6B | $4.1B | ||
| Q2 25 | $1.7B | $4.1B | ||
| Q1 25 | $1.9B | $4.0B | ||
| Q4 24 | $1.7B | $4.0B | ||
| Q3 24 | $2.1B | $4.0B | ||
| Q2 24 | $2.2B | $3.6B | ||
| Q1 24 | $2.3B | $3.5B |
负债/权益比AGLENS
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $184.6M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $171.3M |
| 自由现金流率自由现金流/营收 | -1.5% | 18.6% |
| 资本支出强度资本支出/营收 | 0.2% | 1.4% |
| 现金转化率经营现金流/净利润 | — | 2.04× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $441.3M |
8季度趋势，按日历期对齐
经营现金流AGLENS
| Q4 25 | $-20.5M | $184.6M | ||
| Q3 25 | $-18.2M | $218.0M | ||
| Q2 25 | $-35.1M | $968.0K | ||
| Q1 25 | $-32.0M | $135.2M | ||
| Q4 24 | $16.4M | $81.1M | ||
| Q3 24 | $-7.7M | $33.6M | ||
| Q2 24 | $-18.7M | $10.4M | ||
| Q1 24 | $-47.8M | — |
自由现金流AGLENS
| Q4 25 | $-23.5M | $171.3M | ||
| Q3 25 | $-21.3M | $197.1M | ||
| Q2 25 | $-38.3M | $-32.1M | ||
| Q1 25 | $-35.8M | $104.9M | ||
| Q4 24 | $13.2M | $56.8M | ||
| Q3 24 | $-11.2M | $3.3M | ||
| Q2 24 | $-22.0M | $-25.7M | ||
| Q1 24 | $-50.9M | — |
自由现金流率AGLENS
| Q4 25 | -1.5% | 18.6% | ||
| Q3 25 | -1.5% | 20.7% | ||
| Q2 25 | -2.7% | -3.6% | ||
| Q1 25 | -2.3% | 10.8% | ||
| Q4 24 | 0.9% | 6.3% | ||
| Q3 24 | -0.8% | 0.4% | ||
| Q2 24 | -1.5% | -3.0% | ||
| Q1 24 | -3.2% | — |
资本支出强度AGLENS
| Q4 25 | 0.2% | 1.4% | ||
| Q3 25 | 0.2% | 2.2% | ||
| Q2 25 | 0.2% | 3.7% | ||
| Q1 25 | 0.3% | 3.1% | ||
| Q4 24 | 0.2% | 2.7% | ||
| Q3 24 | 0.2% | 3.4% | ||
| Q2 24 | 0.2% | 4.2% | ||
| Q1 24 | 0.2% | — |
现金转化率AGLENS
| Q4 25 | — | 2.04× | ||
| Q3 25 | — | 3.19× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | -2.64× | 1.40× | ||
| Q4 24 | — | 0.71× | ||
| Q3 24 | — | 0.41× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
ENS
| Energy Systems | $399.5M | 43% |
| Motive Power | $352.0M | 38% |
| Services | $92.6M | 10% |
| Transferred Over Time | $38.2M | 4% |
| Other | $36.8M | 4% |
